Notice Type
Departmental
Notice Title

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Viramune
Active Ingredient: Nevirapine hemihydrate 10.35mg/mL equivalent 10mg/mL nevirapine
Dosage Form: Oral suspension
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Roxane Laboratories Inc, Columbus, Ohio, United States of America
Note: This consent is valid for two years from 2 March 2004.
Dated this 29th day of March 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).